In 2024, Thermal continued to accelerate the understanding and adoption of the world’s most innovative biotechnologies, and achieved numerous PR industry milestones, including:

✅Launching a new breakthrough company each quarter
✅Managing 20+ critical funding and partnership announcements
✅Supporting one of biotech's few (but highly anticipated) IPOs
✅Organizing client speaking sessions at 30+ marquee events such as TED, Aspen Ideas: Health, and Google Deepmind and The Royal Society's AI for Science Summit
✅Securing 200+ (that's not a typo) tier 1 featured media placements and opinion editorials including the cover of Fast Company and immersive coverage in BBC, Bloomberg, CNBC, Endpoints, Fierce, Forbes, Fortune, FT, GEN, MIT Technology Review, NPR, STAT, The Guardian, The New York Times, The New Yorker, TIME, Wired, WSJ...and many more.
✅Winning a coveted place on @MMMnews's Best Places to Work

🌉For 2025, first up is the J.P. Morgan Healthcare Conference - our home event here in San Francisco where once again, we will be facilitating some of the most impactful news and conversations (and prized restaurant reservations!) throughout the week.

🎙️Most notably, don't miss our client CRISPR pioneer Jennifer Doudna's fireside chat sessions with @leilei_wuu at @endpts' #JPM2025 event (Tuesday 14 at 9am) and @natashaloder at @RecursionPharma and @economistimpact's "Era of TechBio" event (Wednesday 15 at 6:30pm).

Looking ahead: If you need to level up your company's PR strategy in 2025, let’s talk. As the agency of choice for the world’s most iconic and innovative scientists, VCs, and biotechs, Thermal can help.